NEW YORK--(BUSINESS WIRE)--Nov. 10, 2003-- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI - News), a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop all-natural Whole Plant Pharmaceuticals and Nutritionals, announced that the company's marketing partner, Nutralife Pharmaceuticals Corp., has signed a distribution agreement with Nutraproducts LLC for the marketing and distribution of Lo-Chol over the Internet.
Nutraproducts LLC has been established for the purpose of selling Lo-Chol over the Internet. Nutraproducts management has been involved in generating over $2.5 million in sales of health and beauty items over the past 3 years through specialty brand internet websites. To retain its distribution rights Nutraproducts must make subsequent purchases of Lo-Chol, aggregating at least 100,000 bottles, over the duration of the agreement, although Nutraproducts is not obligated to make such subsequent purchases.
Nutraproducts LLC has also submitted a purchase order for an initial shipment of 10,000 bottles of Lo-Chol to be sold over the Internet. Advanced Plant Pharmaceuticals, Inc. will produce and begin shipping this initial order within the next thirty days. Nutraproducts' website is currently under construction and will be launched within 30 to 45 days at www.lo-chol.com.
David Lieberman, CEO of Advanced Plant Pharmaceuticals, said, "This agreement with Nutraproducts LLC for internet sales represents our intent to market Lo-Chol through a variety of marketing channels, both domestically and internationally. We are confident that as Nutralife's infomercial campaign rolls out, the telemarketing efforts continue, and Nutralife continues to expand its marketing overseas, APPI will book significant revenues."
Jeffrey Glickman, President of Nutralife Pharmaceuticals, said, "As we continue to expand our marketing network for Lo-Chol with experienced distributors worldwide, we anticipate that our sales momentum for Lo-Chol will build going forward. Our distributors' marketing plans will be supported by the Ed McMahon infomercials in the near future."
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of plant-based dietary supplements. The Company has a patent pending process that utilizes whole plants to manufacture all natural dietary supplements. APPI uses this process to manufacture products, which the company plans to distribute worldwide through various sales distribution contracts or majority-owned spin-off companies. Current products include Sinusol (homeopathic allergy and nasal spray, Garlic, ACA (immune system booster) and the patented Lo-Chol. Corporate website: www.appi.cc
NutraLife Pharmaceuticals, Corp. is a newly established direct response and marketing firm focused on the development and design of marketing programs for a range of commercial products, including production, media buying, fulfillment, direct response, telemarketing, customer service and retail integration and distribution.
FORWARD LOOKING STATEMENTS:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
APPI LC Group, 404-261-1196 or NutraLife Pharmaceuticals Corp. Jeff Glickman, 214-562-6170
Source: Advanced Plant Pharmaceuticals, Inc.